BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)

This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g. BAA-20-100-SOL-0002). Please reference the attached announcement and applicable amendments for specifics. Additionally, please visit https://drive.hhs.gov/. 

_______

Amendment 001:  This amendment to the EZBAA hereby opens the following research areas of interest ("AOI"). Please review the amendment for details of each AOI, including closing dates: 

AOI #15: ReDIRECT
AOI #16: Lab at Home
AOI #17: Digital MCMs
AOI #18: Host-Directed Therapeutics
AOI #19: Healing Lungs
.... Read More

This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g. BAA-20-100-SOL-0002). Please reference the attached announcement and applicable amendments for specifics. Additionally, please visit https://drive.hhs.gov/. 

_______

Amendment 001:  This amendment to the EZBAA hereby opens the following research areas of interest ("AOI"). Please review the amendment for details of each AOI, including closing dates: 

AOI #15: ReDIRECT
AOI #16: Lab at Home
AOI #17: Digital MCMs
AOI #18: Host-Directed Therapeutics
AOI #19: Healing Lungs
.... Read More

This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g. BAA-20-100-SOL-0002). Please reference the attached announcement and applicable amendments for specifics. Additionally, please visit https://drive.hhs.gov/. 

_______

Amendment 001:  This amendment to the EZBAA hereby opens the following research areas of interest ("AOI"). Please review the amendment for details of each AOI, including closing dates: 

AOI #15: ReDIRECT
AOI #16: Lab at Home
AOI #17: Digital MCMs
AOI #18: Host-Directed Therapeutics
AOI #19: Healing Lungs
.... Read More

This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g. BAA-20-100-SOL-0002). Please reference the attached announcement and applicable amendments for specifics. Additionally, please visit https://drive.hhs.gov/. 

_______

Amendment 001:  This amendment to the EZBAA hereby opens the following research areas of interest ("AOI"). Please review the amendment for details of each AOI, including closing dates: 

AOI #15: ReDIRECT
AOI #16: Lab at Home
AOI #17: Digital MCMs
AOI #18: Host-Directed Therapeutics
AOI #19: Healing Lungs
.... Read More

This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g. BAA-20-100-SOL-0002). Please reference the attached announcement and applicable amendments for specifics. Additionally, please visit https://drive.hhs.gov/. 

_______

Amendment 001:  This amendment to the EZBAA hereby opens the following research areas of interest ("AOI"). Please review the amendment for details of each AOI, including closing dates: 

AOI #15: ReDIRECT
AOI #16: Lab at Home
AOI #17: Digital MCMs
AOI #18: Host-Directed Therapeutics
AOI #19: Healing Lungs
.... Read More

This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g. BAA-20-100-SOL-0002). Please reference the attached announcement and applicable amendments for specifics. Additionally, please visit https://drive.hhs.gov/. 

_______

Amendment 001:  This amendment to the EZBAA hereby opens the following research areas of interest ("AOI"). Please review the amendment for details of each AOI, including closing dates: 

AOI #15: ReDIRECT
AOI #16: Lab at Home
AOI #17: Digital MCMs
AOI #18: Host-Directed Therapeutics
AOI #19: Healing Lungs
.... Read More

This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g. BAA-20-100-SOL-0002). Please reference the attached announcement and applicable amendments for specifics. Additionally, please visit https://drive.hhs.gov/. 

_______

Amendment 001:  This amendment to the EZBAA hereby opens the following research areas of interest ("AOI"). Please review the amendment for details of each AOI, including closing dates: 

AOI #15: ReDIRECT
AOI #16: Lab at Home
AOI #17: Digital MCMs
AOI #18: Host-Directed Therapeutics
AOI #19: Healing Lungs
.... Read More

This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g. BAA-20-100-SOL-0002). Please reference the attached announcement and applicable amendments for specifics. Additionally, please visit https://drive.hhs.gov/. 

_______

Amendment 001:  This amendment to the EZBAA hereby opens the following research areas of interest ("AOI"). Please review the amendment for details of each AOI, including closing dates: 

AOI #15: ReDIRECT
AOI #16: Lab at Home
AOI #17: Digital MCMs
AOI #18: Host-Directed Therapeutics
AOI #19: Healing Lungs
.... Read More

This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g. BAA-20-100-SOL-0002). Please reference the attached announcement and applicable amendments for specifics. Additionally, please visit https://drive.hhs.gov/. 

_______

Amendment 001:  This amendment to the EZBAA hereby opens the following research areas of interest ("AOI"). Please review the amendment for details of each AOI, including closing dates: 

AOI #15: ReDIRECT
AOI #16: Lab at Home
AOI #17: Digital MCMs
AOI #18: Host-Directed Therapeutics
AOI #19: Healing Lungs
.... Read More

This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g. BAA-20-100-SOL-0002). Please reference the attached announcement and applicable amendments for specifics. Additionally, please visit https://drive.hhs.gov/. 

_______

Amendment 001:  This amendment to the EZBAA hereby opens the following research areas of interest ("AOI"). Please review the amendment for details of each AOI, including closing dates: 

AOI #15: ReDIRECT
AOI #16: Lab at Home
AOI #17: Digital MCMs
AOI #18: Host-Directed Therapeutics
AOI #19: Healing Lungs
.... Read More

This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g. BAA-20-100-SOL-0002). Please reference the attached announcement and applicable amendments for specifics. Additionally, please visit https://drive.hhs.gov/. 

_______

Amendment 001:  This amendment to the EZBAA hereby opens the following research areas of interest ("AOI"). Please review the amendment for details of each AOI, including closing dates: 

AOI #15: ReDIRECT
AOI #16: Lab at Home
AOI #17: Digital MCMs
AOI #18: Host-Directed Therapeutics
AOI #19: Healing Lungs
.... Read More

This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g. BAA-20-100-SOL-0002). Please reference the attached announcement and applicable amendments for specifics. Additionally, please visit https://drive.hhs.gov/. 

_______

Amendment 001:  This amendment to the EZBAA hereby opens the following research areas of interest ("AOI"). Please review the amendment for details of each AOI, including closing dates: 

AOI #15: ReDIRECT
AOI #16: Lab at Home
AOI #17: Digital MCMs
AOI #18: Host-Directed Therapeutics
AOI #19: Healing Lungs
.... Read More

This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g. BAA-20-100-SOL-0002). Please reference the attached announcement and applicable amendments for specifics. Additionally, please visit https://drive.hhs.gov/. 

_______

Amendment 001:  This amendment to the EZBAA hereby opens the following research areas of interest ("AOI"). Please review the amendment for details of each AOI, including closing dates: 

AOI #15: ReDIRECT
AOI #16: Lab at Home
AOI #17: Digital MCMs
AOI #18: Host-Directed Therapeutics
AOI #19: Healing Lungs
.... Read More

This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g. BAA-20-100-SOL-0002). Please reference the attached announcement and applicable amendments for specifics. Additionally, please visit https://drive.hhs.gov/. 

_______

Amendment 001:  This amendment to the EZBAA hereby opens the following research areas of interest ("AOI"). Please review the amendment for details of each AOI, including closing dates: 

AOI #15: ReDIRECT
AOI #16: Lab at Home
AOI #17: Digital MCMs
AOI #18: Host-Directed Therapeutics
AOI #19: Healing Lungs
.... Read More